News Ceapro Inc.

Equities

CZO

CA1499071076

Delayed Toronto S.E. Other stock markets 03:08:52 2024-04-26 pm EDT			5-day change	1st Jan Change
0.26 ^CAD	+8.33%		+6.12%	+36.84%

Mar. 28	Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions	MT
Mar. 28	Ceapro Brief: Says Received Final Court Approval for Merger with Aeterna Zentaris	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions	Mar. 28	MT
Ceapro Brief: Says Received Final Court Approval for Merger with Aeterna Zentaris	Mar. 28	MT
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris	Mar. 28	GL
Aeterna Zentaris Reports Q4 Net Loss of US$5.6 Million, Provides DETECT Trial Update	Mar. 27	MT
Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency	Mar. 27	MT
Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 million, or $1.16 loss per common share	Mar. 27	MT
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings	Mar. 12	GL
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings	Mar. 12	AQ
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business	Feb. 26	AQ
Ceapro Brief: Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR Arrangement Agreement to Approve Merger of Equals to Create a Diversified Biopharmaceutical Co	Feb. 26	MT
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company	Feb. 26	GL
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business	Feb. 23	GL
Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris	Feb. 15	GL
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro	Feb. 15	AQ
Canadian Investment Regulatory Organization Trade Resumption - CZO	Dec. 14	AQ
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create Diversified Biopharmaceutical Co	Dec. 14	MT
Canadian Investment Regulatory Organization Trading Halt - CZO	Dec. 14	AQ
Aeterna Zentaris and Ceapro Brief: Cos Announcing Merger of Equals to Create a Diversified Biopharmaceutical Co	Dec. 14	MT
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company	Dec. 14	AQ
Ceapro Inc. Announces Dosing of First Patients In Phase 1-2a Study of Avenanthramides	Dec. 13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ceapro Inc.

Equities

CZO

CA1499071076

Summary

Filters